ArticlePloS one2023

Analytical comparability to evaluate impact of manufacturing changes of ARX788, an Anti-HER2 ADC in late-stage clinical development.

Wayne Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.